Eurozone manufacturing shrinking at fastest rate in 6 years

Eurozone manufacturing shrinking at fastest rate in 6 years



A closely watched survey is showing that the manufacturing sector across the 19-country eurozone is shrinking at its fastest rate in six years.

Read More

World shares surge on improved China manufacturing data

World shares surge on improved China manufacturing data



Shares surged Monday in Europe and Asia after the release over the weekend of encouraging manufacturing data in China that suggest government stimulus may be gaining traction.

Read More

Airbnb invests in Indian start-up OYO's series E funding round

Home-renting company Airbnb has invested in Indian hotel reservation start-up OYO's series E funding round, as it dives deeper into the hotel-booking business.

from Reuters: Business News https://ift.tt/2uBQzwj

Read More

Brexit is wrecking Britain's business reputation: Siemens UK head

Britain is wrecking its reputation for business stability with political divisions over Brexit and risks leaving the trading bloc with a hugely damaging "no-deal", the UK head of German industrial giant Siemens has said.

from Reuters: Business News https://ift.tt/2CJGLF6

Read More

EasyJet blames Brexit for weak outlook, shares fall 7 percent

British low-cost carrier easyJet warned on Monday that demand and pricing were suffering from Brexit jitters and a weaker economic outlook, sending shares in European airlines lower.

from Reuters: Business News https://ift.tt/2JXMk8X

Read More

Sports Direct says other Debenhams investors back making Ashley boss

Sports Direct, the sportswear group that is seeking control of Debenhams, said it has been contacted by other shareholders in the department store group expressing their support to install Mike Ashley as Debenhams CEO.

from Reuters: Business News https://ift.tt/2JXJ0L1

Read More

Novartis to pay $310 million for assets from inflammation specialist IFM

Novartis on Monday said it had agreed to pay $310 million upfront, with the possibility for more later, for some research assets of Boston-based inflammation specialist IFM Therapeutics as the Swiss drugmaker expands its immunology pipeline.

from Reuters: Business News https://ift.tt/2OC5gJb

Read More